Cuna, Jane A.

HRN: 24-71-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/06/2024
06/13/2024
IV
300mg
Q6h
Valvular Heart Disease
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Cardiovascular    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: